[HTML] nih.gov

[HTML][HTML] Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature

A Gardellini, F Guidotti, E Maino… - … Cells, Molecules & …, 2021 - ncbi.nlm.nih.gov
# 1: A 27-year-old man presented with hematomas and epistaxis, 10 days after receiving the
first dose of BNT162b2 mRNA vaccine (Comirnaty). Blood tests showed a low platelet count …
Save Cite Cited by 18 Related articles All 6 versions
[PDF] tandfonline.com

Therapeutic Management of Patients with FLT3+ Acute Myeloid Leukemia: Case Reports and Focus on Gilteritinib Monotherapy

…, V Calafiore, M Defina, A Gardellini… - Pharmacogenomics …, 2022 - Taylor & Francis
Acute myeloid leukemia is a malignant disorder of the bone marrow, characterized by
differentiation, clonal expansion, and uncontrolled proliferation of malignant myeloid progenitor …
Save Cite Cited by 5 Related articles All 8 versions
[PDF] tandfonline.com

Plerixafor: what we still have to learn

F Lanza, A Gardellini, D Laszlo… - Expert opinion on …, 2015 - Taylor & Francis
Plerixafor, a hematopoietic stem cell mobilizer, is indicated in combination with G-CSF to
mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent …
Save Cite Cited by 17 Related articles All 7 versions

Core needle biopsy as a front line diagnostic approach for lymphoma patients

…, F Gigli, PR Raviele, A Gardellini… - Hematological …, 2015 - pubmed.ncbi.nlm.nih.gov
… 4 , Angelo Gardellini …
Save Cite Cited by 15 Related articles All 7 versions
[PDF] unimi.it

Deferasirox in the management of iron-overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON-M study)

…, S Malato, E Casartelli, M Maffioli, A Gardellini… - British Journal of …, 2019 - air.unimi.it
… Elli1 Alessandra Iurlo2 Andrea Aroldi1 Marianna Caramella3 Simona Malato4 Elena
Casartelli5 Margherita Maffioli6 Angelo Gardellini7 Maria C. Carraro8 Mariella D’Adda9 Nicola …
Save Cite Cited by 10 Related articles All 7 versions View as HTML
[HTML] nih.gov

[HTML][HTML] Successful mobilisation of peripheral blood stem cells in children using plerixafor: a case report and review of the literature

A Gardellini, A Babic, F Gigli, SJ Liptrott… - Blood …, 2013 - ncbi.nlm.nih.gov
High-dose chemotherapy followed by autologous peripheral blood stem cell (PBSC) support
is a salvage therapy for patients with relapsed or refractory malignant disease. Previous …
Save Cite Cited by 7 Related articles All 6 versions
[PDF] researchgate.net

SDF1-3′ A gene polymorphism is associated with chronic myeloproliferative disease and thrombotic events

…, C Vanelli, O Turri, M Erario, A Gardellini… - Clinical …, 2005 - academic.oup.com
Stromal cell-derived factor-1 (SDF-1), a member of the CXC chemokine family, is constitutively
produced by bone marrow stromal cells, and it induces chemotaxis on a variety of cell …
Save Cite Cited by 16 Related articles All 11 versions
[HTML] mdpi.com

[HTML][HTML] Clinical course and risk factors for in-hospital mortality of 205 patients with SARS-CoV-2 pneumonia in Como, Lombardy Region, Italy

M Turrini, A Gardellini, L Beretta, L Buzzi, S Ferrario… - Vaccines, 2021 - mdpi.com
The aim of this study is to explore risk factors for in-hospital mortality and describe the
effectiveness of different treatment strategies of 205 laboratory-confirmed cases infected with SARS…
Save Cite Cited by 5 Related articles All 14 versions Cached

Thrombotic and infectious complications in patients with autoimmune hemolytic anemia: A multicenter observational study

…, F Morelli, I Tanasi, M Di Perna, S Raso, A Gardellini… - Blood, 2022 - ashpublications.org
Autoimmune hemolytic anemia (AIHA) is a rare disease due to autoantibodies directed against
erythrocyte epitopes. The clinical course is greatly heterogeneous with different anemia …
Save Cite Cited by 1 Related articles
[PDF] academia.edu

R-ESHAP plus pegfilgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory …

J Montoro, G Andreola, A Gardellini, A Babic… - … and Apheresis Science, 2014 - Elsevier
Stem cell (SC) mobilization is significantly influenced by the mobilization schedule in patients
with lymphoma. We evaluated data from 30 patients with relapsed or refractory diffuse …
Save Cite Cited by 4 Related articles All 6 versions